Dr. Reddy’s Omeprazole Case: Is Pediatric Exclusivity Extension Of Patent?

Dr. Reddy's legal rationale for why it should get 180-day exclusivity for 40 mg omeprazole could include an argument that pediatric exclusivity be treated as an extension of the drug's patent life

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet